Clinical Trial

A Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in Multiple Treatments of Adult Upper Limb Spasticity

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This is an open-label, multicenter, phase III clinical study to evaluate the long-term safety and efficacy of multiple treatments with recombinant botulinum toxin type A (YY001) for injection in adult upper limb spasticity
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-15.
Trial Details
NCT Number NCT07478822
Lead Sponsor Chongqing Claruvis Pharmaceutical Co., Ltd.
Conditions Upper Limb Spasticity
Enrollment 300 participants
Start Date 2026-03-27
Primary Completion 2027-06-01 (estimated)
Study Completion 2027-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-02